Evolent Health Statistics

Total Valuation

Evolent Health has a market cap or net worth of $619.77 million. The enterprise value is $1.46 billion.

Market Cap	619.77M
Enterprise Value	1.46B

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, after market close.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Evolent Health has 112.48 million shares outstanding. The number of shares has decreased by -1.41% in one year.

Current Share Class	112.48M
Shares Outstanding	112.48M
Shares Change (YoY)	-1.41%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	1.61%
Owned by Institutions (%)	84.81%
Float	94.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	22.86
PS Ratio	0.33
Forward PS	0.23
PB Ratio	1.56
P/TBV Ratio	n/a
P/FCF Ratio	105.17
P/OCF Ratio	18.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.68, with an EV/FCF ratio of 248.29.

EV / Earnings	n/a
EV / Sales	0.77
EV / EBITDA	19.68
EV / EBIT	n/a
EV / FCF	248.29

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 2.49.

Current Ratio	1.32
Quick Ratio	1.20
Debt / Equity	2.49
Debt / EBITDA	12.53
Debt / FCF	167.22
Interest Coverage	-0.25

Financial Efficiency

Return on equity (ROE) is -65.11% and return on invested capital (ROIC) is -1.31%.

Return on Equity (ROE)	-65.11%
Return on Assets (ROA)	-0.45%
Return on Invested Capital (ROIC)	-1.31%
Return on Capital Employed (ROCE)	-1.09%
Weighted Average Cost of Capital (WACC)	6.56%
Revenue Per Employee	$449,720
Profits Per Employee	-$127,091
Employee Count	4,200
Asset Turnover	0.83
Inventory Turnover	n/a

Taxes

Income Tax	-686,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.55% in the last 52 weeks. The beta is 0.83, so Evolent Health's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-48.55%
50-Day Moving Average	4.04
200-Day Moving Average	4.54
Relative Strength Index (RSI)	73.17
Average Volume (20 Days)	2,532,048

Short Selling Information

The latest short interest is 14.58 million, so 12.97% of the outstanding shares have been sold short.

Short Interest	14.58M
Short Previous Month	14.94M
Short % of Shares Out	12.97%
Short % of Float	15.51%
Short Ratio (days to cover)	5.88

Income Statement

In the last 12 months, Evolent Health had revenue of $1.89 billion and -$533.78 million in losses. Loss per share was -$4.71.

Revenue	1.89B
Gross Profit	381.19M
Operating Income	-16.29M
Pretax Income	-497.21M
Net Income	-533.78M
EBITDA	74.36M
EBIT	-16.29M
Loss Per Share	-$4.71

Full Income Statement

Balance Sheet

The company has $142.03 million in cash and $985.43 million in debt, giving a net cash position of -$843.40 million or -$7.50 per share.

Cash & Cash Equivalents	142.03M
Total Debt	985.43M
Net Cash	-843.40M
Net Cash Per Share	-$7.50
Equity (Book Value)	396.39M
Book Value Per Share	3.52
Working Capital	120.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $33.29 million and capital expenditures -$27.40 million, giving a free cash flow of $5.89 million.

Operating Cash Flow	33.29M
Capital Expenditures	-27.40M
Depreciation & Amortization	90.65M
Net Borrowing	-93.44M
Free Cash Flow	5.89M
FCF Per Share	$0.05

Full Cash Flow Statement

Margins

Gross margin is 20.18%, with operating and profit margins of -0.86% and -26.29%.

Gross Margin	20.18%
Operating Margin	-0.86%
Pretax Margin	-26.32%
Profit Margin	-26.29%
EBITDA Margin	3.94%
EBIT Margin	-0.86%
FCF Margin	0.31%

Dividends & Yields

Evolent Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.41%
Shareholder Yield	1.41%
Earnings Yield	-86.13%
FCF Yield	0.95%

Analyst Forecast

The average price target for Evolent Health is $5.88, which is 6.72% higher than the current price. The consensus rating is "Buy".

Price Target	$5.88
Price Target Difference	6.72%
Analyst Consensus	Buy
Analyst Count	15
Revenue Growth Forecast (3Y)	21.64%
EPS Growth Forecast (3Y)	82.94%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Evolent Health has an Altman Z-Score of 0.38 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.38
Piotroski F-Score	4